TFDP1, transcription factor Dp-1, 7027

N. diseases: 56; N. variants: 3
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0016382
Disease: Flushing
Flushing
0.020 Biomarker phenotype BEFREE Recently, laropiprant, a DP1 receptor antagonist, has been used in combination with niacin to abolish the prostaglandin D<sub>2</sub>-(PGD<sub>2</sub>)-induced flushing. 28842638 2017
CUI: C0016382
Disease: Flushing
Flushing
0.020 Biomarker phenotype BEFREE These studies suggest that DP1 receptor antagonism may be an effective means to suppress NA-induced flushing in humans. 16617107 2006